Baxter

SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 11, 2023 in the Class Action Filed on Behalf of Baxter International Inc.(BAX) Shareholders

Retrieved on: 
Thursday, August 31, 2023
Telephone, COST, Baxter, CLASS, Baxter International, HOW, NYSE, Face, BAX

NEW YORK, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.

Key Points: 
  • NEW YORK, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Baxter you have until September 11, 2023 to petition the court for lead plaintiff status.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Baxter International Inc. (BAX)

Retrieved on: 
Wednesday, August 30, 2023
Face, Baxter, Baxter International, Suite, Court, Defendant, GPM, NYSE, News

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Baxter securities during the Class Period, you may move the Court no later than September 11, 2023 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

BAXTER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Baxter International Inc. - BAX

Retrieved on: 
Wednesday, August 30, 2023
FREE, Baxter, Baxter International, Lawyer, District court, NYSE, Financial adviser, Security (finance)

NEW ORLEANS, Aug. 29, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 11, 2023 to file lead plaintiff applications in a securities class action lawsuit against Baxter International Inc. (NYSE: BAX), if they purchased the Company’s securities between May 12, 2022 and February 8, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Aug. 29, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 11, 2023 to file lead plaintiff applications in a securities class action lawsuit against Baxter International Inc. (NYSE: BAX), if they purchased the Company’s securities between May 12, 2022 and February 8, 2023, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the Northern District of Illinois.
  • Baxter investors should visit us at https://claimsfiler.com/cases/nyse-bax-4/ or call toll-free (844) 367-9658.
  • Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

BAXTER INTERNATIONAL, INC. (NYSE: BAX) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Baxter International, Inc.

Retrieved on: 
Tuesday, August 29, 2023
Baxter International, Baxter, District court, Advertising, Complaint, Court, Action Replay, News, NYSE, Kidney disease, Security (finance)

If you purchased or acquired Baxter securities, and/or would like to discuss your legal rights and options please visit Baxter International, Inc.

Key Points: 
  • If you purchased or acquired Baxter securities, and/or would like to discuss your legal rights and options please visit Baxter International, Inc.
  • If you wish to serve as lead plaintiff, you must move the Court no later than September 11, 2023.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX

Retrieved on: 
Tuesday, August 29, 2023
Titan, Face, Class, Baxter, Baxter International, Advertising, Court, NYSE, I-Space (Chinese company), Insurance, Tobacco

WHAT TO DO NEXT: To join the Baxter class action, go to https://rosenlegal.com/submit-form/?case_id=17664 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Baxter class action, go to https://rosenlegal.com/submit-form/?case_id=17664 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Baxter International Inc.: Please contact the Portnoy Law Firm to recover your losses; September 11, 2023 deadline

Retrieved on: 
Monday, August 28, 2023
Baxter, Baxter International, NYSE, Pharmaceutical industry

LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- ​The Portnoy Law Firm advises Baxter International Inc. ("Baxter" or the “Company”) (NYSE: BAX) investors that a lawsuit filed on behalf of investors that purchased Baxter securities between May 25, 2022 and February 8, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- ​ The Portnoy Law Firm advises Baxter International Inc. ("Baxter" or the “Company”) (NYSE: BAX) investors that a lawsuit filed on behalf of investors that purchased Baxter securities between May 25, 2022 and February 8, 2023, both dates inclusive (the “Class Period”).
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, August 28, 2023
Proterra, Face, Baxter, Law, MANTRA, Sea Ltd, Complaint, Suite, Investment, Defendant, Growth, FDA, Security (finance)

LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Baxter International Inc. (BAX) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Monday, August 28, 2023
CASE, LLP, Face, Telephone, COST, Baxter International, Levi, CLASS, NEXT, Court, NYSE, Cryptocurrency, Baxter

NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Baxter investors who were adversely affected by alleged securities fraud between May 25, 2022 and February 8, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    BAX investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioXcel, Seagate, and Baxter and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, August 28, 2023
Acceleration, P.C, Institutional review board, BIS, Shareholder, Office of Inspector General, U.S. Department of Health and Human Services, Face, Seagate Technology, Jordan Economic and Commerce Bureau, Software, Baxter International, Baxter, Policy, Record, EAR, Person, Seagate, Nursing, Name, Food and Drug Administration Amendments Act of 2007, Dementia, HDD, Patient, Nature, Defendant, United, FDA, Therapy, Entity List, News, NYSE, Agitation, Food, Safety, Commerce, U.S. Department of Commerce Office of Security, Pharmaceutical industry, Cryptocurrency, Audit, Huawei

On December 15, 2021, the Company announced that it had initiated a program to evaluate BXCL501 for the treatment of acute agitation associated with Alzheimer’s disease.

Key Points: 
  • On December 15, 2021, the Company announced that it had initiated a program to evaluate BXCL501 for the treatment of acute agitation associated with Alzheimer’s disease.
  • The Company announced that the program consisted of two randomized, double-blind, placebo-controlled studies: TRANQUILITY II and TRANQUILITY III.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • For more information on the Baxter class action go to: https://bespc.com/cases/BAX

Calling All Baxter International Inc. (BAX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!

Retrieved on: 
Monday, August 28, 2023
Baxter, Court, NYSE, Face, Complaint, Person, Security (finance)

Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/bax .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/bax .
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.